Free Trial

National Health Investors, Inc. (NYSE:NHI) to Issue Quarterly Dividend of $0.90

National Health Investors logo with Finance background
Remove Ads

National Health Investors, Inc. (NYSE:NHI - Get Free Report) announced a quarterly dividend on Tuesday, February 25th, Wall Street Journal reports. Shareholders of record on Monday, March 31st will be paid a dividend of 0.90 per share by the real estate investment trust on Friday, May 2nd. This represents a $3.60 dividend on an annualized basis and a yield of 5.03%. The ex-dividend date is Monday, March 31st.

National Health Investors has increased its dividend by an average of 7.8% annually over the last three years. National Health Investors has a payout ratio of 107.8% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect National Health Investors to earn $4.66 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 77.3%.

National Health Investors Stock Up 0.4 %

Shares of National Health Investors stock traded up $0.28 during midday trading on Friday, hitting $71.53. The company had a trading volume of 476,557 shares, compared to its average volume of 203,196. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The company has a 50 day moving average of $68.72 and a 200 day moving average of $75.02. National Health Investors has a 52-week low of $56.70 and a 52-week high of $86.13. The stock has a market capitalization of $3.27 billion, a P/E ratio of 24.58, a P/E/G ratio of 4.42 and a beta of 1.06.

Remove Ads

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $85.75 million during the quarter, compared to analyst estimates of $81.13 million. On average, equities analysts predict that National Health Investors will post 4.41 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Truist Financial cut their price target on shares of National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a report on Monday, December 23rd. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $76.60.

Check Out Our Latest Stock Analysis on National Health Investors

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Recommended Stories

Dividend History for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads